Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Antibodies 2014, 3(1), 116-129; doi:10.3390/antib3010116
Review

B Cell Tolerance in Health and Disease

1
, 2
 and 3,*
Received: 21 November 2013; in revised form: 11 February 2014 / Accepted: 13 February 2014 / Published: 19 February 2014
(This article belongs to the Special Issue B Cells and Immunological Tolerance)
View Full-Text   |   Download PDF [377 KB, updated 20 February 2014; original version uploaded 19 February 2014]
Abstract: B lymphocyte receptors are generated randomly during the bone marrow developmental phase of B cells. Hence, the B cell repertoire consists of both self and foreign antigen specificities necessitating specific tolerance mechanisms to eliminate self-reactive B cells. This review summarizes the major mechanisms of B cell tolerance, which include clonal deletion, anergy and receptor editing. In the bone marrow presentation of antigen in membrane bound form is more effective than soluble form and the role of dendritic cells in this process is discussed. Toll like receptor derived signals affect activation of B cells by certain ligands such as nucleic acids and have been shown to play crucial roles in the development of autoimmunity in several animal models. In the periphery availability of BAFF, a B cell survival factor plays a critical role in the survival of self-reactive B cells. Antibodies against BAFF have been found to be effective therapeutic agents in lupus like autoimmune diseases. Recent developments are targeting anergy to control the growth of chronic lymphocytic leukemia cells.
Keywords: B cells; tolerance; Toll-like receptors; B-1 B cells; autoimmunity B cells; tolerance; Toll-like receptors; B-1 B cells; autoimmunity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Gururajan, M.; Sindhava, V.J.; Bondada, S. B Cell Tolerance in Health and Disease. Antibodies 2014, 3, 116-129.

AMA Style

Gururajan M, Sindhava VJ, Bondada S. B Cell Tolerance in Health and Disease. Antibodies. 2014; 3(1):116-129.

Chicago/Turabian Style

Gururajan, Murali; Sindhava, Vishal J.; Bondada, Subbarao. 2014. "B Cell Tolerance in Health and Disease." Antibodies 3, no. 1: 116-129.

Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert